Dilution / Toxic financing
Concurrent Private Placement Warrants: The Second Half of a Registered Direct
Why registered direct offerings often come with unregistered warrants in a concurrent private placement, and how to count the shares they add later.
6 min readLast verified
The short version
A registered direct offering is a sale of shares, negotiated with one or a few investors, off an existing shelf registration. It is documented in a 424B5 prospectus supplement. Very often the same press release adds a second piece: the investors also receive warrants, but those warrants are issued in a separate, unregistered "concurrent private placement".
So one deal has two legal halves. The shares (and any pre-funded warrants) are registered and can be sold immediately. The warrants, and the shares they become, are unregistered, and the company typically promises to register them for resale later. For counting dilution, the second half is easy to miss because it is not described as part of the registered offering's size.
Why the warrants are split off
Several reasons push companies toward this structure:
- Shelf capacity. A company with a public float under $75 million is subject to the baby shelf limit in General Instruction I.B.6 of Form S-3: it can sell no more than one-third of its public float under the shelf in any 12 months. Registering the warrant shares would use up that capacity. Issuing the warrants privately does not.
- Speed. The registered shares can close within a day or two; the warrant shares can be registered afterwards.
- Investor economics. The warrants are the "sweetener" that makes the investor willing to buy at the agreed price.
The private half relies on an exemption such as Section 4(a)(2), which is why it is disclosed under 8-K Item 3.02 (unregistered sales) as well as in the 424B5.
A real example, read line by line
A prospectus supplement on Form 424B5 filed on 2026-09-30 (accession 0001193125-26-407980) described a registered direct offering of Class A common stock and pre-funded warrants, with this concurrent private placement:
In a concurrent private placement with the investor (the "Concurrent Private Placement"), we are issuing unregistered warrants to purchase up to 357,000 shares of Class A Common Stock (the "Warrants"). The Warrants have an exercise price of $15.00 per share of Class A Common Stock, are exercisable six months following their issuance, and will expire five and a half years from issuance.
The offering table in the same document gives a combined price of $14.00 per share of common stock and privately placed warrant ($13.9999 per pre-funded warrant and privately placed warrant), a total offering price of $4,997,984.30, a placement agent cash fee of 6.00% of aggregate proceeds, and proceeds before expenses of $4,698,105.24. The pre-funded warrants covered up to 157,000 shares at an exercise price of $0.0001, subject to a 4.99% beneficial ownership blocker (9.99% at the investor's election).
Working the numbers from those disclosed figures:
| Item | Source or calculation | Value |
|---|---|---|
| Common shares sold | Disclosed | 200,000 |
| Pre-funded warrants sold | Disclosed | 157,000 |
| Units sold (each with a warrant) | 200,000 + 157,000 | 357,000 |
| Cross-check of total price | 357,000 × $14.00, less $0.0001 on each pre-funded warrant | $4,997,984.30 |
| Private placement warrants | Disclosed | 357,000 |
| Warrant coverage | 357,000 ÷ 357,000 | 100% |
| Warrant exercise price vs. offering price | $15.00 vs. $14.00 | 7.1% above |
The same document opens by stating that the company was offering, to a single institutional investor in a registered direct offering, 200,000 shares of Class A common stock together with pre-funded warrants for up to 157,000 shares. The registered half therefore delivered 357,000 shares (counting the pre-funded warrants, which are exercisable for $0.0001), and the private placement created the right to 357,000 more. Total potential new shares from the deal are 714,000, twice what the registered share count alone suggests.
A hypothetical with the dilution worked through
Hypothetical Company X has 10,000,000 shares outstanding at $2.50. It sells 2,000,000 shares at $2.00 in a registered direct, with 150% warrant coverage in a concurrent private placement at an exercise price of $2.25.
- New shares now: 2,000,000 (count rises 20%, to 12,000,000).
- New warrants: 3,000,000 at $2.25.
- Fully diluted after the deal: 15,000,000, a 50% increase over the original count.
- Gross proceeds: $4,000,000 now, and up to $6,750,000 more if every warrant is exercised for cash.
All figures hypothetical. If the warrants allow cashless exercise when no resale registration is effective, exercise can deliver fewer shares and no cash.
Where the terms are disclosed
- The 424B5, under "The Offering", "Concurrent Private Placement" and "Plan of Distribution". It states warrant count, exercise price, exercisability and term, and the placement agent's fees and any agent warrants.
- The 8-K, Items 1.01 and 3.02, with the securities purchase agreement, form of warrant and placement agency agreement as exhibits.
- The warrant form, for anti-dilution adjustments, ownership blockers and cashless exercise terms.
- A later resale registration (resale S-1 or S-3), which registers the warrant shares and names the investor as a selling stockholder.
Phrases to search: "concurrent private placement", "Private Placement Warrants", "Common Warrants", "Series A Warrants", "exercisable six months", "Section 4(a)(2)", "Placement Agent Warrants", "registration statement providing for the resale".
Related structures
The same split shows up in a PIPE where common shares are also unregistered, and in public offerings where shares and warrants are sold together as units. What distinguishes the concurrent private placement is the mix: registered shares that can trade immediately, unregistered warrants that wait for a resale registration.
How to check a company on Signal8
- A company's Dilution tab (example) separates recent offerings from outstanding warrants, so a new block of warrants issued alongside a registered direct can be checked against the offering it came from. Coverage focuses on small caps; missing rows mean not measured.
- The dilution screener compares dilution-related data across companies.
- Registered directs appear on the live SEC filings feed as 424B5 filings, usually alongside an 8-K.
FAQ
What is a concurrent private placement?
It is an unregistered sale of securities, usually warrants, that happens at the same time as a registered offering to the same investors. The registered half is sold off a shelf with a prospectus supplement; the private half relies on an exemption from registration and is disclosed under 8-K Item 3.02. The company typically agrees to register the warrant shares for resale later.
Why are the warrants not registered with the shares?
Often because the company's shelf capacity is limited, for example by the baby shelf rule for companies with a public float under $75 million. Issuing the warrants privately avoids using that capacity. It also lets the registered shares close quickly, with the warrant shares registered for resale afterwards.
Do private placement warrants count as dilution?
They are potential dilution. They add no shares until exercised, but they are part of the fully diluted share count. When the stock trades above the exercise price, holders can exercise and receive new shares, so they belong in any estimate of how many shares a deal can ultimately create.
How do I find the warrant exercise price?
The 424B5's description of the concurrent private placement states it, along with when the warrants become exercisable and when they expire. The form of warrant filed with the 8-K contains the full terms, including any later adjustments to the price.
Sources
- SEC accession 0001193125-26-407980 Form 424B5, filed 2026-09-30, registered direct offering of Class A common stock and pre-funded warrants with unregistered warrants for up to 357,000 shares in a concurrent private placement
Terms in this guide
- Registered direct offering
- A sale of newly issued shares to a small group of investors arranged by a placement agent, made off an effective shelf registration so the shares are freely tradeable at closing.
- Pre-funded warrant
- A warrant sold for almost the full share price up front, leaving a nominal exercise price such as $0.0001, used so a buyer can stay under ownership limits until it exercises.
- Baby shelf rule
- The Form S-3 limit (General Instruction I.B.6) that caps companies with under $75 million of public float at selling one-third of that float in primary offerings in any 12 months.
- Placement agent
- A broker-dealer hired to find investors for a company's offering on a best-efforts basis, paid a cash fee and often warrants, without committing to buy the securities itself.
- S-1 resale registration
- A registration statement that registers shares already issued or issuable to named investors so they can sell them publicly; the company itself usually receives no proceeds from those sales.
- Form 424B5 prospectus supplement
- A prospectus supplement filed under SEC Rule 424(b)(5) to document a specific offering made off an effective shelf, stating the securities sold, the price and the use of proceeds.
- Warrant overhang
- The block of shares that could be created if a company's outstanding warrants are exercised. It is potential dilution that does not yet appear in the shares outstanding figure.
- PIPE (private investment in public equity)
- A private sale of unregistered shares, warrants or convertibles by a public company to selected investors, usually followed by a registration statement so the buyers can resell.
- Ownership blocker
- A clause that stops a holder from converting or exercising a security if doing so would push its beneficial ownership above a set limit, typically 4.99% or 9.99% of the common stock.
Put it to work
Try it on Signal8
See this in live data with Dilution screener.
Also useful: Company research pages · Live SEC filings feed
Related guides
6 min read
Reading Counterparty Disclosures: Holders, Placement Agents and Selling Shareholders
How to read the sections of a prospectus and 8-K that name who is on the other side of a financing, what they are paid, and how many shares they can sell.
6 min read
Warrant Overhang: Counting the Shares That Do Not Exist Yet
What warrant overhang is, how to total it from the warrant table in a 10-Q, and how cash, cashless and pre-funded exercises change the share count.
5 min read
Warrant Inducements: Repricing Old Warrants for Cash and New Warrants
How warrant inducement deals work, why holders get new warrants for exercising early, and how to calculate the shares added now and later.
6 min read
Ownership Blockers: Why 4.99% and 9.99% Caps Do Not Limit Total Dilution
How beneficial ownership blockers work, why they cap a holder's stake at any moment but not the total shares issued, and a worked convert-and-sell cycle.
Educational content only. Signal8 is not a broker-dealer or investment adviser, and nothing here is a recommendation to buy or sell any security.